Categories
Change Password!
Reset Password!
To compare the efficacy and safety of three approaches used to reduce pain and improve fibromyalgia symptoms.
Fibromyalgia is a chronic pain disorder with
an estimated prevalence of 2-8% in the United States. Gabapentin and
Osteopathic Manipulation Medicine (OMM) both were reported to be recommended
for the treatment of fibromyalgia. But none of the studies compare the efficacy
of both the procedures. Therefore, in the present study, the author demonstrated
that OMM treatment and gabapentin are the safe and clinically efficacious
treatment option for the fibromyalgia.
To compare the efficacy and safety of three approaches used to reduce pain
and improve fibromyalgia symptoms.
A total of 40 individuals who met the American College of Rheumatology
(ACR) 1990 criteria for fibromyalgia from Contra Costa, Solano, and Sonoma
counties of California from 2006 to 2009. These patients divided into three
groups and received osteopathic manipulative medicine (OMM) only, 900 mg/day
gabapentin alone, and combined treatment of gabapentin plus OMM. Advanced
medical students administered OMM therapy for 30 min, once a week. The analysis
was completed in 8 weeks, six weeks of treatment with initial and final visits.
The outcome measures involved a Clinical Global Impression of Health (CGI),
Wong-Baker FACES Pain Rating Scale (WBF), number of tender points, and
Fibromyalgia Impact Questionnaire (FIQ).
The analysis was completed by 29 individuals out of 11 received OMM only, 8
taken gabapentin only and 10 obtained gabapentin plus OMM. A significant
clinical improvement based on WBF was seen among the groups OMM alone and
combined treatment of gabapentin plus OMM than gabapentin-only. Further, the
decline in the CGI scale was showed only among the patients of OMM group. No
statistically meaningful differences were noticed with the number of tender
points or FIQ. The changes across the groups also were not statistically
significant. This is to be presumed in a feasibility analysis with small sample
size.
All these findings validate that the gabapentin and OMM treatment is clinically efficient and
safe to treat constitutional and somatic symptoms and pain related to fibromyalgia.
However, further investigation using the new ACR 2010 Fibromyalgia criteria is
required to validate these outcomes.
J Altern Complement Med. 2018 Jan 3
Fibromyalgia with Gabapentin and Osteopathic Manipulative Medicine: A Pilot Study.
Marske C et al.
Comments (0)